Finance

Beta
Lists
CTX:TSE
Crescita Therapeutics Inc
CA$0.79
0.00%
(0.00) 1D
Jun 4, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for CTX...
Open
CA$0.79
High
CA$0.79
Low
CA$0.79
Mkt. cap
14.71M
Avg. vol.
9.62K
Volume
1.16K
52-wk high
CA$0.79
52-wk low
CA$0.40
EPS
-CA$0.02
Beta
-0.23
Shares outstanding
18.61M
No. of employees
65
Open
CA$0.79
High
CA$0.79
Low
CA$0.79
Mkt. cap
14.71M
Avg. vol.
9.62K
Volume
1.16K
52-wk high
CA$0.79
52-wk low
CA$0.40
EPS
-CA$0.02
Beta
-0.23
Shares outstanding
18.61M
No. of employees
65
News stories
From sources across the web
About Crescita Therapeutics Inc
CEO-
Employees65
Founded2016
Headquarters-
SectorPharmaceutical industry
Websitecrescitatherapeutics.com
Last report
May 11, 2026
Fiscal period
Q1 2026
EPS / Est. (CAD)
- / -
Revenue / Est. (CAD)
5.64M / -
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.23M
5.39M
5.96M
5.64M
Cost of goods sold
2.41M
2.54M
3.27M
2.99M
Cost of revenue
2.41M
2.54M
3.27M
2.99M
Research and development expenses
141.00K
138.00K
164.00K
139.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.75M
2.50M
3.25M
3.52M
Operating expense
3.24M
3.02M
3.06M
3.85M
Total operating expenses
5.65M
5.56M
6.34M
6.84M
Operating income
583.00K
-162.00K
-381.00K
-1.20M
Other non operating income
-18.00K
1.12M
366.00K
-
EBT including unusual items
798.00K
753.00K
-702.00K
-1.16M
EBT excluding unusual items
798.00K
1.03M
-36.00K
-1.16M
Income tax expense
-
-
9.00K
-
Effective tax rate
-
-
-1.28%
-
Other operating expenses
-
-
-
-
Net income
798.00K
753.00K
-711.00K
-1.16M
Net profit margin
12.80%
13.96%
-11.94%
-20.58%
Earnings per share
-
-
-
-
Interest and investment income
131.00K
38.00K
63.00K
55.00K
Interest expense
-12.00K
-10.00K
-8.00K
-30.00K
Net interest expenses
119.00K
28.00K
55.00K
25.00K
Depreciation and amortization charges
353.00K
384.00K
-354.00K
195.00K
EBITDA
936.00K
222.00K
-114.50K
-818.00K
Gain or loss from assets sale
-
-
-1.47M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer